BIDU vs PRLD · rev $18.46B vs rev $10.3M
Baidu Inc (BIDU) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Baidu Inc (BIDU) is a internet content & information company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported BIDU revenue for 2025-12-31 was $18.46B. Net income was $799.0M. Revenue was up 1.2% from 2024-12-31 to 2025-12-31. BIDU currently screens at market cap $37.98B.
Latest reported PRLD revenue for 2026-06-30 was $10.3M. Net income was -$24.3M. PRLD currently screens at market cap $346.5M.
BIDU currently screens at market cap $37.98B. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the BIDU and PRLD stock pages for the full models.
Not investment advice.